These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 7593643
21. Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency. Brown NJ, Bradford J, Wang Z, Lea W, Ma L, Ma J, Vaughan DE, Fogo AB. Kidney Int; 2007 Jul; 72(1):72-81. PubMed ID: 17429342 [Abstract] [Full Text] [Related]
22. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production. Brown NJ, Kim KS, Chen YQ, Blevins LS, Nadeau JH, Meranze SG, Vaughan DE. J Clin Endocrinol Metab; 2000 Jan; 85(1):336-44. PubMed ID: 10634408 [Abstract] [Full Text] [Related]
23. HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells. Kunieda Y, Nakagawa K, Nishimura H, Kato H, Ukimura N, Yano S, Kawano H, Kimura S, Nakagawa M, Tsuji H. Thromb Res; 2003 Jun 01; 110(4):227-34. PubMed ID: 14512087 [Abstract] [Full Text] [Related]
24. Angiotensin type 1 receptor is linked to inhibition of nitric oxide production in pulmonary endothelial cells. Zhao X, Li X, Trusa S, Olson SC. Regul Pept; 2005 Dec 15; 132(1-3):113-22. PubMed ID: 16242794 [Abstract] [Full Text] [Related]
25. Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension. Roncal C, Orbe J, Rodriguez JA, Belzunce M, Beloqui O, Diez J, Páramo JA. Cardiovasc Res; 2004 Jul 01; 63(1):176-85. PubMed ID: 15194475 [Abstract] [Full Text] [Related]
31. Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kagami S, Kuhara T, Okada K, Kuroda Y, Border WA, Noble NA. Kidney Int; 1997 Mar 01; 51(3):664-71. PubMed ID: 9067897 [Abstract] [Full Text] [Related]
32. Angiotensin II and bradykinin regulate the expression of P-selectin on the surface of endothelial cells in culture. Tayeh MA, Scicli AG. Proc Assoc Am Physicians; 1998 Mar 01; 110(5):412-21. PubMed ID: 9756092 [Abstract] [Full Text] [Related]
33. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells. Benndorf R, Böger RH, Ergün S, Steenpass A, Wieland T. Circ Res; 2003 Sep 05; 93(5):438-47. PubMed ID: 12881481 [Abstract] [Full Text] [Related]
34. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling. Weisberg AD, Albornoz F, Griffin JP, Crandall DL, Elokdah H, Fogo AB, Vaughan DE, Brown NJ. Arterioscler Thromb Vasc Biol; 2005 Feb 05; 25(2):365-71. PubMed ID: 15576638 [Abstract] [Full Text] [Related]
35. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature. Muller C, Endlich K, Barthelmebs M, Helwig JJ. Br J Pharmacol; 1997 Dec 05; 122(7):1495-501. PubMed ID: 9421301 [Abstract] [Full Text] [Related]